I think I should phrased my questions differently and instead asked why RT002 is being left of this list and lists like this one. Is it partly because analysts are not considering RT002 to be a novel drug?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.